Featured News
Do you know where your cancer drugs come from?
Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests
Technology shines the light on ovarian cancer treatments
Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration
Chemistry innovator widening, quickening uses of spectrometry
New treatment approach uses killer cells to treat deadly brain tumors
Purdue scientist identifies new target for wide array of cancers
Novel testing platform designed for breast cancer cells
$2 million SBIR grant fast-tracks cancer drug platform technology, which aims to better treat relapse
Stretchable, wearable coils may make MRI, other medical tests easier on patients
A technology devised to help reduce injection pain, swelling from some best-selling drugs
Pair of Purdue students continuing legacy of Tyler Trent in supporting cancer research
Dr. Andrew Mesecar, Deputy Director of the Purdue Center for Cancer Research, is working with global scientists in the race against the coronavirus
Local news story on Dr. Mesecar's work with coronavirus here
Legislation to support cancer research passes Indiana Senate
Novel techniques for mining patented gene therapies offer promising treatment options for cancers, other diseases
Purdue-discovered 'flourescent markers' to illuminate cancer, improve outcomes, receives FDA fast track as Phase 3 clinical trial begins
Study indentifies interaction that promotes cancerous state in cells
Pancreatic cancer 'time machine' exposes plot twist in cell growth and invasion
This 'lemon' could help machine learning create better drugs
Tyler Trent's donated cells to help a trio of new osteosarcoma research projects
An engineering approach to reduce the pain of chemotherapy
Chemistry Professor Gaurav Chopra wins multiple ASPIRE Awards
Getting cancer drugs to the brain is difficult - but a new 'road map' might make it easier
Cancer Bioinformatics Q&A - Purdue and IU partners in cutting edge cancer technology
Purdue Professor creates a device to help keep cancer medication costs low
A Conversation with Dr. Thompson from the Cancer Letter
Could anthrax help fight bladder cancer?
Structuralbiology used to gain insight into the mechanism of action of covalentinhibitors of the deubiquitinase UCHL1
Can Herbicides Cause Breast Cancer? Purdue and INSERM scientists discover a piece of the puzzle
Big data approach to cancer focus of new Purdue partnership
Aug. 27, 2019. WEST LAFAYETTE, Ind. — Improving the use of biostatistics, predictive modeling and data science in cancer research is the focus of a new partnership between Purdue University and the Frederick National Laboratory for Cancer Research.
Timothy L. Ratliff, distinguished professor of comparative pathobiology and Purdue's Robert Wallace Miller Director of the Center for Cancer Research, said the partnership will include the appointment and exchange of scientific staff, sabbatical opportunities, student training and postdoctoral fellowships.
"The Purdue University Center for Cancer Research is honored to enter into a partnership with the Frederick National Laboratory to enhance and accelerate educational and research activities in the field of computational biology and predictive modeling," Ratliff said. "Working with the outstanding investigators at Frederick National Laboratory will benefit our students and faculty and will enable us to have a greater impact on the field."
Purdue and Frederick National Laboratory also will conduct cooperative research in protein crystallization in microgravity.
Dr. Ethan Dmitrovsky, director of the Frederick National Laboratory and president of Leidos Biomedical Research Inc., said the agreement brings together two leaders in cancer research.
"The Purdue University Center for Cancer Research conducts world-class basic research that has led to significant advances in the field," he said. "This mutually beneficial partnership will allow some of the best minds in cancer research to come together to accelerate research discoveries that will ultimately benefit patients."
The Purdue Cancer Research Center conducts basic research on the cellular causes and potential treatment of cancers. The Center is one of only seven National Cancer Institute-designate basic research cancer centers in the nation.
Writer: Steve Tally, 765-494-9809, steve@purdue.edu, @sciencewriter
Sources: Timothy L. Ratliff, 7650494-9129, tlratliff@purdue.edu
Epigenetics offer puzzling twists and turns, but also possible cancer treatements
'A case for personalized medicine in the search for answers about cancer
'A first for cancer research': New Approach to study tumors
New anticancer agents have potential to better control tumor growth in nearly every cancer type
